194 related articles for article (PubMed ID: 24962700)
1. Pleiotropic roles of mTOR complexes in haemato-lymphopoiesis and leukemogenesis.
Hoshii T; Matsuda S; Hirao A
J Biochem; 2014 Aug; 156(2):73-83. PubMed ID: 24962700
[TBL] [Abstract][Full Text] [Related]
2. Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells.
Hoshii T; Kasada A; Hatakeyama T; Ohtani M; Tadokoro Y; Naka K; Ikenoue T; Ikawa T; Kawamoto H; Fehling HJ; Araki K; Yamamura K; Matsuda S; Hirao A
Proc Natl Acad Sci U S A; 2014 Mar; 111(10):3805-10. PubMed ID: 24567410
[TBL] [Abstract][Full Text] [Related]
3. [Roles of mTOR signalings in hematopoiesis and leukemogenesis].
Hirao A
Rinsho Ketsueki; 2015 Jun; 56(6):601-5. PubMed ID: 26256868
[TBL] [Abstract][Full Text] [Related]
4. Steady-state kinetic and inhibition studies of the mammalian target of rapamycin (mTOR) kinase domain and mTOR complexes.
Tao Z; Barker J; Shi SD; Gehring M; Sun S
Biochemistry; 2010 Oct; 49(39):8488-98. PubMed ID: 20804212
[TBL] [Abstract][Full Text] [Related]
5. mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action.
Soliman GA; Acosta-Jaquez HA; Dunlop EA; Ekim B; Maj NE; Tee AR; Fingar DC
J Biol Chem; 2010 Mar; 285(11):7866-79. PubMed ID: 20022946
[TBL] [Abstract][Full Text] [Related]
6. Mammalian target of rapamycin and tuberous sclerosis complex.
Wataya-Kaneda M
J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
[TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin and the kidney. I. The signaling pathway.
Lieberthal W; Levine JS
Am J Physiol Renal Physiol; 2012 Jul; 303(1):F1-10. PubMed ID: 22419691
[TBL] [Abstract][Full Text] [Related]
8. Deconstructing mTOR complexes in regulation of Glioblastoma Multiforme and its stem cells.
Jhanwar-Uniyal M; Jeevan D; Neil J; Shannon C; Albert L; Murali R
Adv Biol Regul; 2013 May; 53(2):202-10. PubMed ID: 23231881
[TBL] [Abstract][Full Text] [Related]
9. Differing effects of rapamycin and mTOR kinase inhibitors on protein synthesis.
Huo Y; Iadevaia V; Proud CG
Biochem Soc Trans; 2011 Apr; 39(2):446-50. PubMed ID: 21428917
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic / mammalian target protein of rapamycin signaling in hematopoietic stem cells and leukemia.
Hirao A; Hoshii T
Cancer Sci; 2013 Aug; 104(8):977-82. PubMed ID: 23648144
[TBL] [Abstract][Full Text] [Related]
11. Influence of mTOR in energy and metabolic homeostasis.
Haissaguerre M; Saucisse N; Cota D
Mol Cell Endocrinol; 2014 Nov; 397(1-2):67-77. PubMed ID: 25109278
[TBL] [Abstract][Full Text] [Related]
12. RAD 001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia.
Mancini M; Petta S; Martinelli G; Barbieri E; Santucci MA
J Cell Biochem; 2010 Feb; 109(2):320-8. PubMed ID: 20014066
[TBL] [Abstract][Full Text] [Related]
13. [mTORC1 and sirolimus: a link with fertility].
Tartarin P; Froment P
Med Sci (Paris); 2013 Feb; 29(2):200-5. PubMed ID: 23452608
[TBL] [Abstract][Full Text] [Related]
14. Stoichiometry and assembly of mTOR complexes revealed by single-molecule pulldown.
Jain A; Arauz E; Aggarwal V; Ikon N; Chen J; Ha T
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17833-8. PubMed ID: 25453101
[TBL] [Abstract][Full Text] [Related]
15. Role of PRAS40 in Akt and mTOR signaling in health and disease.
Wiza C; Nascimento EB; Ouwens DM
Am J Physiol Endocrinol Metab; 2012 Jun; 302(12):E1453-60. PubMed ID: 22354785
[TBL] [Abstract][Full Text] [Related]
16. Focus Issue: demystifying mTOR signaling.
Gough NR
Sci Signal; 2009 Apr; 2(67):eg5. PubMed ID: 19383973
[TBL] [Abstract][Full Text] [Related]
17. The role of mechanistic target of rapamycin in maintenance of glomerular epithelial cells.
Yao Y; Inoki K
Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):28-34. PubMed ID: 26625863
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of MAPK potentiates the anti-angiogenic efficacy of mTOR inhibitors.
Dormond-Meuwly A; Roulin D; Dufour M; Benoit M; Demartines N; Dormond O
Biochem Biophys Res Commun; 2011 Apr; 407(4):714-9. PubMed ID: 21439267
[TBL] [Abstract][Full Text] [Related]
19. mTORC signaling in hematopoiesis.
Wang X; Chu Y; Wang W; Yuan W
Int J Hematol; 2016 May; 103(5):510-8. PubMed ID: 26791377
[TBL] [Abstract][Full Text] [Related]
20. mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition.
Limon JJ; So L; Jellbauer S; Chiu H; Corado J; Sykes SM; Raffatellu M; Fruman DA
Proc Natl Acad Sci U S A; 2014 Nov; 111(47):E5076-85. PubMed ID: 25385646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
